Community Intervention for Child Development
Trial Summary
What is the purpose of this trial?
Structural inequities and historical underinvestment in marginalized communities create developmental contexts that constrain access to high-quality education, healthcare, stable housing, and other critical resources. This study evaluates effects of a strengths-based, community-led intervention on young children and their families, which aims to buffer structural inequities while recognizing families' strengths. Between ages 18-36 months, English- and Spanish-speaking families consented and were randomly assigned to the intervention group (ParentChild+) or the active control group (FamilyNutrition+). Each group received 92 contacts from a specialist matched with their demographics. For the intervention group, contact focused on supporting parents and children's early learning, and families received a book or toy each week; for the control group, contact focused on supporting child nutrition, and families received a small food voucher each week. The current study evaluates whether the intervention altered parents' mental health, children's early environments, and/or children's test performance and brain development.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on community support and child development rather than medical treatments, so it's unlikely that medication changes are required.
What data supports the effectiveness of the treatment FamilyNutrition+, ParentChild+?
Research shows that early intervention services and parent-led developmental training can significantly improve developmental outcomes in children, especially those at high risk or with developmental delays. Additionally, parenting programs have been effective in reducing parental distress and improving child behavior, suggesting that similar community-based interventions like FamilyNutrition+ and ParentChild+ could be beneficial.12345
Is the Community Intervention for Child Development safe for humans?
The research articles reviewed do not provide specific safety data for the Community Intervention for Child Development or its related programs like FamilyNutrition+ and ParentChild+. However, they discuss the feasibility and effectiveness of developmental screenings and community programs, which are generally considered safe and beneficial for child development.678910
How is the ParentChild+ treatment different from other treatments for child development?
ParentChild+ is unique because it focuses on early intervention by involving both children and their parents in a community setting, providing therapeutic day care and mother-child interaction groups, which is different from traditional individual or clinic-based programs. This approach emphasizes social and economic support, parental education, and developmental screening, making it more comprehensive and community-oriented compared to other treatments.710111213
Research Team
Allyson P Mackey, PhD
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for English- and Spanish-speaking families with children aged 18-36 months, aiming to support child development in communities facing structural inequities. It's not specified who can't join, so it seems open to those meeting the age and language criteria.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Families participate in the ParentChild+ or FamilyNutrition+ program, receiving 92 contacts over 46 weeks.
Follow-up
Participants are monitored for changes in parental mental health, parenting behaviors, and child outcomes.
Treatment Details
Interventions
- FamilyNutrition+
- ParentChild+
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor